This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
A fat belly is bad for your heart   Doctors should measure central obesity to assess cardiovascular ... (21 Apr 2018)
Can early counselling prevent post traumatic ... A randomized controlled trial published in the current issue of ... (21 Apr 2018)
Are antidepressants safe in patients with ... An investigation published in the current issue of Psychotherapy ... (21 Apr 2018)
WASP Course in Bahrain WASP Course, led by Prof Victor Grech and Prof Charles Savona ... (24 Apr 2018)
Psychotherapy may be of help in multiple ... A study published in the current issue of Psychotherapy and ... (21 Apr 2018)
Thursday, 23 November 2017 11:54

Benzodiazepines increase mortality in persons with Alzheimer’s disease Featured

Rate this item
(0 votes)

Benzodiazepine and related drug use is associated with a 40 per cent increase in mortality among persons with Alzheimer’s disease, according to a new study from the University of Eastern Finland. The findings were published in the International Journal of Geriatric Psychiatry.


The study found that the risk of death was increased right from the initiation of benzodiazepine and related drug use. The increased risk of death may result from the adverse events of these drugs, including fall-related injuries, such as hip fractures, as well as pneumonia and stroke.

The study was based on the register-based MEDALZ (Medication Use and Alzheimer’s Disease) cohort, which includes all persons diagnosed with Alzheimer’s disease in Finland during 2005-2011. Persons who had used benzodiazepines and related drugs previously were excluded from this study, and therefore, the study population consisted of 10,380 new users of these drugs. They were compared with 20,760 persons who did not use these drugs.

Although several treatment guidelines state that non-pharmacological options are the first-line treatment of anxiety, agitation and insomnia in persons with dementia, benzodiazepines and related drugs are frequently used in the treatment of these symptoms. If benzodiazepine and related drug use is necessary, these drugs are recommended for short-term use only. These new results encourage more consideration for benzodiazepine and related drug use in persons with dementia.



Source: University of Eastern Finland

Full bibliographic information:

Risk of death associated with new benzodiazepine use among persons with Alzheimer’s disease – a matched cohort study. International Journal of Geriatric Psychiatry, published online November 15, 2017.

Read 647 times Last modified on Thursday, 23 November 2017 13:24

TheSynapse Videos

0
0
0
0
0
0

Latest news

Highlights

  • WASP Course in Bahrain

    WASP Course, led by Prof Victor Grech and Prof Charles Savona Ventura, has recently organised a course in Bahrain. Co-hosted with Arabian Gulf University, the course, on how to write a scientific paper, focused on quantitative analysis methods and was targeted for medical doctors and allied health professionals.

    Written on April 24, 2018 Read more...

SPONSOR MESSAGE

February 27, 2017
0
February 27, 2017
0

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…